Process View
The process in which an organism effects a change in the structure or processes of a symbiont organism. The symbiont is defined as the smaller of the organisms involved in a symbiotic interaction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "modification by host of symbiont morphology or physiology"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SP1 | Sp1 transcription factor | 1.000 | ||
| IL8 | interleukin 8 | 0.944 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.906 | Mouse | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.899 | Mouse | |
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.894 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.858 | Mouse | |
| JUN | jun proto-oncogene | 0.777 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.753 | ||
| HDAC1 | histone deacetylase 1 | 0.695 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.607 | Human | |
| ARID1A | AT rich interactive domain 1A (SWI-like) | 0.605 | ||
| IL1B | interleukin 1, beta | 0.496 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.446 | ||
| ESR1 | estrogen receptor 1 | 0.442 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.422 | Human | |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.399 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.399 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.383 | ||
| ATF3 | activating transcription factor 3 | 0.370 | ||
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.351 | ||
| SMAD3 | SMAD family member 3 | 0.347 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.333 | ||
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.315 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.310 | ||
| CREBBP | CREB binding protein | 0.307 | Human | |
| SMAD4 | SMAD family member 4 | 0.223 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.209 | ||
| PAX3 | paired box 3 | 0.192 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.178 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.176 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.160 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.146 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.143 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.140 | Human | |
| JUNB | jun B proto-oncogene | 0.128 | Human | |
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.122 | Human | |
| SMN1 | survival of motor neuron 1, telomeric | 0.107 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.106 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.100 | Human | |
| DPP4 | dipeptidyl-peptidase 4 | 0.099 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.094 | ||
| ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.087 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.085 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.082 | ||
| EP300 | E1A binding protein p300 | 0.080 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.078 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.077 | Human | |
| CCL3 | chemokine (C-C motif) ligand 3 | 0.076 | ||
| SS18 | synovial sarcoma translocation, chromosome 18 | 0.069 | ||
| RAB5A | RAB5A, member RAS oncogene family | 0.067 | ||
| HTT | huntingtin | 0.063 | ||
| FOSL1 | FOS-like antigen 1 | 0.061 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.059 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.058 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.058 | Human | |
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.058 | Mouse | |
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.057 | ||
| IDE | insulin-degrading enzyme | 0.057 | ||
| OCIAD1 | OCIA domain containing 1 | 0.056 | ||
| TBP | TATA box binding protein | 0.055 | ||
| TP53 | tumor protein p53 | 0.054 | ||
| TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 0.047 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.046 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.045 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.045 | Human | |
| POU2F1 | POU class 2 homeobox 1 | 0.045 | Human | |
| YY1 | YY1 transcription factor | 0.044 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.043 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.042 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.041 | ||
| AR | androgen receptor | 0.041 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.039 | ||
| JDP2 | Jun dimerization protein 2 | 0.039 | ||
| SIRT1 | sirtuin 1 | 0.037 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.037 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.035 | Human | |
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.034 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.033 | ||
| UTY | ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | 0.033 | ||
| TIAL1 | TIA1 cytotoxic granule-associated RNA binding protein-like 1 | 0.032 | ||
| TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 0.031 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.031 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.031 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.030 | ||
| TNF | tumor necrosis factor | 0.030 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.030 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.029 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.028 | ||
| SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.027 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.027 | ||
| SELE | selectin E | 0.027 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.026 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.026 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.026 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.026 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.026 | ||
| IL10 | interleukin 10 | 0.025 | ||
| CH25H | cholesterol 25-hydroxylase | 0.025 | ||
| CRP | C-reactive protein, pentraxin-related | 0.024 | Human | |
| GLIS2 | GLIS family zinc finger 2 | 0.024 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.023 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.022 | ||
| DARC | Duffy blood group, chemokine receptor | 0.022 | ||
| TCF4 | transcription factor 4 | 0.021 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.021 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.021 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.021 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.021 | ||
| BTRC | beta-transducin repeat containing | 0.020 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.020 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.020 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.020 | Human | |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.019 | ||
| IFNG | interferon, gamma | 0.019 | ||
| TOP2B | topoisomerase (DNA) II beta 180kDa | 0.018 | ||
| CD83 | CD83 molecule | 0.018 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.018 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.018 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.017 | ||
| RUNX1 | runt-related transcription factor 1 | 0.017 | ||
| SMAD7 | SMAD family member 7 | 0.017 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.017 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.017 | ||
| INHBA | inhibin, beta A | 0.017 | ||
| CREBZF | CREB/ATF bZIP transcription factor | 0.017 | ||
| HIC1 | hypermethylated in cancer 1 | 0.016 | ||
| RAB14 | RAB14, member RAS oncogene family | 0.016 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.016 | ||
| INADL | InaD-like (Drosophila) | 0.016 | ||
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.016 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.015 | Human | |
| JUND | jun D proto-oncogene | 0.015 | Human | |
| LTF | lactotransferrin | 0.015 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.015 | ||
| ARRB1 | arrestin, beta 1 | 0.015 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.015 | ||
| IL11 | interleukin 11 | 0.015 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.015 | ||
| PABPN1 | poly(A) binding protein, nuclear 1 | 0.015 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.014 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.014 | ||
| APTX | aprataxin | 0.014 | ||
| DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 0.014 | ||
| JUP | junction plakoglobin | 0.014 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.014 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.014 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.014 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.013 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.013 | ||
| IL1A | interleukin 1, alpha | 0.013 | ||
| IL7R | interleukin 7 receptor | 0.013 | ||
| GLTPD1 | glycolipid transfer protein domain containing 1 | 0.013 | ||
| TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 0.013 | ||
| IL2RB | interleukin 2 receptor, beta | 0.013 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.013 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.013 | ||
| HSF2 | heat shock transcription factor 2 | 0.013 | ||
| IL21R | interleukin 21 receptor | 0.013 | ||
| LEF1 | lymphoid enhancer-binding factor 1 | 0.012 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.012 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.012 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.012 | ||
| NCL | nucleolin | 0.012 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.012 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.012 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.012 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.012 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.012 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.012 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.012 | ||
| IRF4 | interferon regulatory factor 4 | 0.012 | ||
| APCS | amyloid P component, serum | 0.011 | ||
| ICOS | inducible T-cell co-stimulator | 0.011 | ||
| ATF2 | activating transcription factor 2 | 0.011 | Human | |
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.011 | ||
| EMD | emerin | 0.011 | ||
| EGR1 | early growth response 1 | 0.011 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.011 | ||
| PRTN3 | proteinase 3 | 0.011 | ||
| MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0.011 | ||
| SMAD9 | SMAD family member 9 | 0.011 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.011 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.011 | ||
| PRKCD | protein kinase C, delta | 0.011 | ||
| DDX3Y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 0.011 | ||
| MPO | myeloperoxidase | 0.011 | ||
| PSEN1 | presenilin 1 | 0.011 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.011 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
| HMOX2 | heme oxygenase (decycling) 2 | 0.010 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.010 | ||
| LAMC3 | laminin, gamma 3 | 0.010 | ||
| CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.010 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.010 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.010 | ||
| BCL2A1 | BCL2-related protein A1 | 0.010 |